Why is Metropolis Healt falling/rising?

As of 22-Jul, Metropolis Healthcare Ltd is experiencing a price increase, currently at 1,984.00, reflecting a rise of 48.3 or 2.5%. The stock has shown a positive trend today, gaining after three consecutive days of decline and outperforming its sector by 1.76%. It reached an intraday high of Rs 1985, and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. However, there has been a significant drop in investor participation, with delivery volume falling by 79.63% compared to the 5-day average. Despite this, the company benefits from high management efficiency, indicated by a return on capital employed (ROCE) of 26.87% and a low debt-to-equity ratio, alongside substantial institutional holdings at 45.58%.
In the broader market context, Metropolis Healthcare's short-term performance has been strong, with a 1-week return of +6.04%, contrasting with the Sensex, which has declined by 0.47% over the same period. However, the stock's year-to-date performance shows a decline of 3.85%, while the Sensex has gained 5.18%. This suggests that while the stock is currently rising, it faces challenges in maintaining long-term growth, as indicated by its poor sales growth and recent negative quarterly results. The stock's valuation appears expensive relative to its fundamentals, with a price-to-book value of 7.7, which may affect investor sentiment moving forward.